SBRT with concurrent chemoradiation in stage III NSCLC: first results of the phase I Hybrid trial

被引：0
|
作者：
Peulen, H. [1 ]
Sonke, J. J. [1 ]
Van der Bijl, E. [1 ]
Damen, E. [1 ]
Belderbos, J. [1 ]
机构：
[1] Netherlands Canc Inst, Radiat Oncol, Amsterdam, Netherlands
来源：
RADIOTHERAPY AND ONCOLOGY | 2016年 / 119卷
关键词：
D O I：
10.1016/S0167-8140(16)31526-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PV-0277
引用
收藏
页码：S129 / S129
页数：1
相关论文
共 50 条
  • [21] Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months
    Navarro-Martin, Arturo
    Aso, Samantha
    Cacicedo, Jon
    Arnaiz, Maria
    Navarro, Valentin
    Rosales, Samuel
    de Blas, Rodolfo
    Ramos, Ricard
    Guedea, Ferran
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (07) : 1101 - 1111
  • [22] A Prospective Study of SBRT Boost to Residual Disease in Stage III NSCLC: Updated Results
    McGarry, R. C.
    Feddock, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S651 - S651
  • [23] A phase I study of dasatinib with concurrent chemoradiation for stage III non-small cell lung cancer
    Khurshid, Humera
    Dipetrillo, Thomas
    Ng, Thomas
    Mantripragada, Kalyan
    Birnbaum, Ariel
    Berz, David
    Radie-Keane, Kathy
    Perez, Kimberly
    Constantinou, Maria
    Luppe, Denise
    Schumacher, Andrew
    Leonard, Kara
    Safran, Howard
    FRONTIERS IN ONCOLOGY, 2012, 2 : 7 - 11
  • [24] Consolidation Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation for Patients with Unresectable Stage III NSCLC
    Durm, G. A.
    Mamdani, H.
    Althouse, S.
    Jabbour, S.
    Ganti, A.
    Jalal, S.
    Chesney, J.
    Naidoo, J.
    Hrinczenko, B.
    Fidler, M. J.
    Leal, T.
    Feldman, L.
    Fujioka, N.
    Hanna, N.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S64 - S64
  • [25] Phase Ib study of neoadjuvant concurrent chemoradiation plus durvalumab followed by surgery and adjuvant durvalumab for resectable stage III NSCLC.
    Lee, Jiyun
    Cho, Jaeho
    Lee, Chang
    Lee, Chang Young
    Lee, Jin Gu
    Kim, Dae Joon
    Shim, Hyo Sup
    Lim, Sun Min
    Kim, Hye Ryun
    Cho, Byoung Chul
    Hong, Min Hee
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] Long-term result of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT
    Lindberg, K.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S98 - S99
  • [27] Demographic Disparities in SBRT Utilization for Stage I NSCLC
    Corso, C. D.
    Park, H. S.
    Moreno, A. C.
    Kim, A. W.
    Yu, J. B.
    Husain, Z.
    Decker, R. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S575 - S575
  • [28] SBRT Versus Sublobar Resection for Stage I NSCLC
    Ackerson, B.
    Hong, J. C.
    Kelsey, C. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E436 - E436
  • [29] Proton SBRT for Medically Inoperable Stage I NSCLC
    Westover, Kenneth D.
    Seco, Joao
    Adams, Judith A.
    Lanuti, Michael
    Choi, Noah C.
    Engelsman, Martijn
    Willers, Henning
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : 1021 - 1025
  • [30] Early results of a phase I trial of the HIV protease inhibitor nelfinavir with concurrent chemoradiotherapy (CT-RT) for stage IIIA/IIIB NSCLC
    Rengan, Ramesh
    Mick, Rosemarie
    Lin, Lilie L.
    Maity, Amit
    Gupta, Anjali K.
    Evans, Tracey L.
    Stevenson, James
    Langer, Corey J.
    Kucharczuk, John
    Friedberg, Joseph
    Prendergast, Susan
    Driesbaugh, Jason
    Hahn, Stephen M.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S519 - S519
12345